FPRX - Five Prime Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts10101010
Avg. Estimate-0.95-0.87-3.79-2.89
Low Estimate-1.11-1.16-4.27-4.7
High Estimate-0.72-0.11-2.78-1.08
Year Ago EPS-1.37-1.12-4.13-3.79
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts10101010
Avg. Estimate5.23M9.83M23.72M49.77M
Low EstimateN/AN/A8.7MN/A
High Estimate13.5M50M63.68M139M
Year Ago SalesN/A4.03M49.87M23.72M
Sales Growth (year/est)N/A143.90%-52.40%109.80%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-1.15-1.32-1.06-0.9
EPS Actual-1.37-1.12-1.02-0.99
Difference-0.220.20.04-0.09
Surprise %-19.10%15.20%3.80%-10.00%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.95-0.87-3.79-2.89
7 Days Ago-0.95-0.87-3.79-2.89
30 Days Ago-0.95-0.87-3.79-2.91
60 Days Ago-1.02-0.93-3.96-2.91
90 Days Ago-1.02-0.88-3.78-3.05
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesFPRXIndustrySectorS&P 500
Current Qtr.30.70%N/AN/A-0.02
Next Qtr.22.30%N/AN/A0.07
Current Year8.20%N/AN/A-0.02
Next Year23.70%N/AN/A0.14
Next 5 Years (per annum)-59.64%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A